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Abstract
Importance—Prospective studies linking shift work to coronary heart disease (CHD) have been 
inconsistent and limited by short follow-up.
Objective—Determine whether rotating night shift work is associated with CHD risk.
Design, Setting and Participants—Prospective cohort study of 189,158 initially healthy 
women followed over 24 years in the Nurses' Health Studies (NHS (1988-2012): N=73,623, and 
NHS2 (1989-2013): N=115,535).
Exposure—Questionnaire-based lifetime history of rotating night shift work (≥3 night shifts/
month, plus day and evening shifts) at baseline; also updated every 2-4yrs in NHS2.
Main Outcomes and Measures—Incident CHD, i.e. non-fatal myocardial infarction, CHD 
death, angiogram-confirmed angina pectoris, coronary artery bypass grafting (CABG), stents, and 
angioplasty.
Results—During follow-up, 7,303 incident CHD cases in NHS (mean age at baseline: 54.5yrs) 
and 3,519 in NHS2 (34.8yrs) occurred. In multivariable adjusted Cox proportional hazards 
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models, increasing years of baseline rotating night shift work were associated with a significantly 
higher CHD risk in both cohorts (NHS: age-standardized incidence rate (IR)<5yrs per 100,000 
person-years=435.1, hazard ratio (HR)<5yrs=1.02, 95% confidence interval (CI)=0.97-1.08, 
IR5-9yrs=525.7, HR5-9yrs=1.12, 95%CI=1.02-1.22, IR≥10yrs=596.9, HR≥10yrs=1.18, 
95%CI=1.10-1.26; Ptrend<0.001; NHS2: IR<5yrs=130.6, HR<5yrs=1.05, 95%CI=0.97-1.13; 
IR5-9yrs=151.6, HR5-9yrs=1.12, 95%CI=0.99-1.26; HR≥10yrs=178.0, HR≥10yrs=1.15, 
95%CI=1.01-1.32; Ptrend=0.01), compared to women who never worked rotating night shifts 
(NHS: IRnever=425.5, NHS2: IRnever=122.6). In NHS, the association between duration of rotating 
night shift work and CHD was stronger in the first half of follow-up (IR<5yrs=382.4, 
HR<5yrs=1.10, 95%CI=1.01-1.21, IR5-9yrs=483.1, HR5-9yrs=1.19, 95%CI=1.03-1.39, 
IR≥10yrs=494.4, HR≥10yrs=1.27, 95%CI =1.13-1.42, Ptrend <0.001) than in the second half 
(IR<5yrs=424.8, HR<5yrs=0.98, 95%CI=0.92-1.05, IR5-9yrs=520.7, HR5-9yrs=1.08, 
95%CI=0.96-1.21, IR≥10yrs=556.2, HR≥10yrs=1.13, 95%CI =1.04-1.24, Ptrend=0.004, 
PInteraction=0.02), suggestive of waning risk after cessation of shift work. Longer time since 
quitting shift work was associated with decreased CHD risk among ever shift workers in NHS2 
(Ptrend<0.001).
Conclusions and Relevance—Among women who worked as registered nurses, longer 
duration of rotating night shift work was associated with a statistically significant, but small 
absolute increase in CHD risk. Further research is needed to explore whether the association is 
related to specific work hours and individual characteristics.
Introduction
Societal and economic demands push towards an increase of 24-hour availability, in health 
care settings as well as service and security industries. The resulting disruption of social and 
biological rhythms, occurring especially during shift work, has been hypothesized to 
increase chronic disease risk,1-5 and suggestive evidence supports an association between 
shift work and coronary heart disease (CHD), metabolic disorders and cancer.6
In 1995, Kawachi et al. examined the association between rotating night shift work and 
CHD in the Nurses' Health Study (NHS) over four years of follow-up and reported a 51% 
significant increase in CHD risk (nonfatal myocardial infarction and CHD death) among 
women with more than six years of rotating night shift work after multivariate adjustment 
(incidence rate per 100,000 person-years, 156.1 compared to 75.4 in women who never 
worked night shifts).7 A recent systematic meta-analysis reported a 24% elevated CHD risk 
associated with most types of shift work, but noted significant heterogeneity in exposure 
assessment and study designs across studies.8 This present study re-assessed the association 
of rotating night shift work and coronary health in the Nurses' Health Studies (NHS and 
NHS2) with 24 years of follow-up, and examined manifestations of coronary heart disease 
(angiogram-confirmed angina pectoris, coronary artery stents, angioplasty and coronary 
artery bypass grafts (CABG)), in addition to non-fatal myocardial infarction and CHD death. 
Additionally, possible differences in this association over time, including effects of time 
since quitting shift work, were explored. The study also examined the excess risk of shift 
work in women without diabetes, hypertension, or hypercholesterolemia – potential 
comorbid mediators of coronary heart disease.
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Methods
Study Population
The NHS and NHS2 are ongoing, prospective cohort studies. The NHS began in 1976 when 
121,701 registered US nurses aged 30 to 55 years responded to a baseline questionnaire.9 
The NHS2 started in 1989, including 116,430 registered US nurses aged 25 to 42 years. In 
both cohorts, biennial follow-up questionnaires have been mailed since then to update 
information on medical history, lifestyle factors, and newly-diagnosed diseases. Follow-up 
rates were high in both cohorts, with approximately 90% participation at each 2-year cycle. 
This study was reviewed and approved by the Brigham and Women's Institutional Review 
Board (IRB); completion of the self-administered questionnaire was considered informed 
consent, so the requirement for oral or written consent was waived.
Rotating Night Shift Work Assessment
In the NHS, lifetime years of exposure to rotating night shift work (defined as 3 or more 
night shifts per month, in addition to day and evening shifts) was queried once, in 1988. In 
the NHS2, women indicated in 1989 how many years of rotating night shift work they had 
worked, with updates in 1991, 1993, 1997, 2001, 2005, and 2007; retrospective assessments 
for shift work in 1995, 1999 and 2003 were included on the 2001 and 2005 questionnaires, 
respectively. The analyses used baseline assessments of lifetime shift work history in each 
cohort (1988 for NHS, and 1989 for NHS2), as well as cumulative shift work exposure 
through 2007 in NHS2. In all analyses, night shift work information was carried forward for 
one questionnaire cycle in case of missing data.
Ascertainment of CHD
On baseline and follow-up questionnaires, participants were asked to report physician-
diagnosed CHD events. Those who reported nonfatal myocardial infarction (MI) were asked 
for medical record access, so that exposure-blinded physicians could confirm self-reported 
nonfatal MI. Nonfatal MI was confirmed using the World Health Organization criteria, 
which required diagnostic electrocardiographic findings or elevated enzyme levels in 
addition to typical symptoms.10 Participant deaths were identified through the National 
Death Index, next of kin, or postal authorities, with primary cause of death being determined 
by autopsy reports, hospital records and death certificates. The primary outcome was 
incident coronary heart disease, including self-reported cases of CABG, angina pectoris 
(confirmed by angiogram), angioplasty and coronary artery stents, in addition to nonfatal MI 
and CHD death (including fatal MI), whichever came first. Secondary analyses were 
restricted to nonfatal MI and CHD death.
Covariate Assessment
In both cohorts, biennial questionnaires were used to collect information on medical history, 
anthropometric data, diet and lifestyle. Most variables were updated biennially from baseline 
onward, physical activity and dietary data were obtained approximately every four years. 
Dietary habits were assessed using a semi-quantitative, validated food frequency 
questionnaire (FFQ),11 calculating the Alternative Healthy Eating Index (AHEI), which has 
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previously been found to be a reliable predictor of coronary heart disease in these cohorts.12 
Parity was updated until 1996 and 2009 for NHS and NHS2, respectively, and subsequently 
carried forward. Husband's educational attainment (a proxy for socio-economic status 
assessed in 1992 in NHS and in 1999 in NHS2), family history of MI before the age of 60 
(1976 and 1984 in NHS, and 1989, 1997 and 2001 in NHS2), and race (2004 in NHS and 
1989 and 2005 in NHS2) were not updated throughout follow-up. Usual sleep duration 
assessed in 1986, 2000 and 2008 (NHS) and 2001 (NHS2), and social support (assessed by 
asking whether the women have a confidant) in 1992, 2000, 2004 and 2008 (NHS) and in 
1993 (NHS2) were not regularly updated throughout follow-up.
Statistical Analyses
Age- and multivariable-adjusted Cox proportional hazards models were used to estimate 
hazard ratios (HR) and 95% confidence intervals (CI) across rotating night shift work 
categories (none, <5, 5 to 9, and ≥10 years). Women with no history of rotating night shift 
work comprised the reference category in all analyses. P-trend calculations were based on 
the midpoint of rotating night shift work categories, with the highest category conservatively 
set to 10; the reported p-value was based on the Wald test. The proportional hazards 
assumption was tested by including an interaction of shift work (i.e., mid-point of 
categories) by time in all models, and its significance was evaluated using the Wald statistic. 
Sensitivity analyses restricted the outcome was restricted to nonfatal MI and CHD death. 
Additional sensitivity analyses restricted to participants with no baseline history of major 
comorbidities potentially mediating CHD (i.e., diabetes, hypertension, and 
hypercholesterolemia) and censored women who reported any of these conditions 
throughout follow-up.
The following cardiovascular disease risk factors were included in multivariable-adjusted 
models: family history of MI before age 60yrs, diet quality (AHEI,12 without the alcohol 
and multivitamin components, in quintiles), physical activity (MET-hours/week; in 
quintiles), body-mass index (BMI, in kg/m2: <25, 25-29, 30-35, >35), cumulative pack-years 
smoked (continuous), alcohol intake (none, 0.1–5, 5.1–10, 10.1–20, >20g/day), parity 
(nulliparous, 1, 2, ≥3 children), menopausal status (pre- or postmenopausal), 
postmenopausal hormone use (pre-menopausal, ever, never), race (white, black, or other), 
husband's highest educational level (high school diploma or less, college degree, or graduate 
school level or similar), multivitamin use (yes/no), acetaminophen use (yes/no), non-
steroidal anti-inflammatory drug use (yes/no), aspirin use (yes/no), hypertension (yes/no), 
diabetes (yes/no), and hypercholesterolemia (yes/no). In additional analyses, models were 
adjusted for sleep duration (<6, 6-7, 8-9, ≥10 hours/day) and social support (yes/no). 
Dummy variables were used to indicate missing covariate values. For missing information 
on pack-years of smoking, the median among smokers was imputed; in case of missing 
BMI, information was carried forward once. On average, 9.5% of covariate information was 
missing across 24 years of follow-up.
In NHS2, analyses also examined the association between cumulative time since quitting 
rotating night shift work (never, current, <12, 12-24, >24 years) and CHD risk. Time since 
quitting rotating night shift work was estimated based on lifetime reports of exposure in 
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1989 and updated shift work information throughout follow-up. If women reported rotating 
night shifts at baseline only, time since quitting shift work was estimated by subtracting 21 
years (assumed age at starting shift work) and the lower bound of the categorically reported 
duration of rotating night shift work from their age in 1989.
In additional secondary analyses, potential effect modification by BMI (<25, 25-30, and 
>30kg/m2) was examined, adjusting continuously for BMI within each stratum. To evaluate 
potential interactions, the log likelihood ratio test was used to compare models with and 
without cross-product interaction terms; corresponding p-values were based on chi-square 
statistics.
The a priori hypothesis was that rotating night shift work increased CHD risk, and all 
secondary analyses were pre-planned. Analyses were conducted with SAS software, version 
9.4. (SAS Institute, Inc., Cary, NC) with a 2-sided significance threshold of p<0.05.
Results
A total of 103,525 NHS participants answered the 1988 questionnaire. Of these, women 
with CHD, stroke or cancer (N=14,065) and those who did not answer the shift work 
question in 1988 (N=15,837) were excluded, leaving 73,623 women for analysis. In NHS2, 
116,430 women answered the baseline questionnaire (1989), of whom 895 reported stroke or 
CHD prior to baseline, so that after the same exclusions 115,535 women were left for 
analysis. For the NHS2 analysis with updated shift work information, women who did not 
answer shift work questions for two consecutive cycles (on average 8.7% per cycle) were 
censored. Women were excluded from further follow-up after any self-reported stroke, 
incident CHD, or death.
During 24 years of follow up, a total of 10,822 incident CHD cases were observed (7,303 in 
NHS and 3,519 in the younger NHS2). Table 1 describes age and age-adjusted (within 
cohort) characteristics of the study population across categories of lifetime years of rotating 
night shift work at baseline. Compared to women in NHS, women in NHS2 were younger, 
more likely to be nulliparous, had slightly lower alcohol consumption, reported less pack-
years of smoking, less comorbid conditions, and took less medication and multi-vitamin 
supplements. With increasing duration of rotating night shift work, women were heavier in 
both cohorts. Also, a lower proportion of women had husbands with graduate-level 
education across categories of shift work, and pack-years of smoking and self-reports of 
hypertension increased in NHS; in NHS2, a greater proportion of nulliparous women and 
acetaminophen users were observed with increasing duration of rotating night shift work.
Compared to women without a history of rotating night shift work (IRNHS=425.5 and 
IRNHS2=122.6), women who worked <5 years of shift work at baseline did not have a 
significantly increased CHD risk in age-adjusted analyses, (Tables 2 and 3), but there was a 
significant association between longer durations of shift work and CHD risk (NHS: 
HR5-9yrs=1.21, 95%CI=1.11-1.33, IR5-9yrs=525.7; HR≥10yrs=1.36, 95%CI=1.27-1.46, 
Ptrend<0.001, IR≥10yrs=596.9; NHS2: HR5-9yrs=1.22, 95%CI=1.08-1.38, IR5-9yrs=151.6; 
HR≥10yrs=1.34, 95%CI=1.17-1.53, IR≥10yrs=178.0, Ptrend<0.001).
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Multivariable (MV) adjustment for known CHD risk factors attenuated these estimates, but 
the elevated risk observed for ≥5yrs of shift work persisted in NHS (MVHR5-9yrs=1.12, 
95%CI=1.02-1.22; MVHR≥10yrs=1.18, 95%CI=1.10-1.26, Ptrend<0.001), and for ≥10 yrs of 
shift work in NHS2 (MVHR5-9yrs=1.12, 95%CI=0.99-1.26; MVHR≥10yrs=1.15, 
95%CI=1.01-1.32, Ptrend=0.01).
In NHS, there was a significant interaction between rotating night shift work exposure and 
time (by 2-year period, Table 2, Pinteraction<0.001), suggesting that CHD risk associated with 
shift work changes over time. During the first half of follow-up, higher effect estimates and 
significantly elevated risks were observed also with shorter durations of shift work exposure 
(MVHR<5yrs=1.10, 95%CI=1.01-1.21; IR<5yrs=382.4; MVHR5-9yrs=1.19, 
95%CI=1.03-1.39; IR5-9yrs=483.1, MVHR≥10yrs=1.27, 95%CI=1.13-1.42, IR≥10yrs=494.4, 
Ptrend<0.001, Pinteraction=0.02 for first vs. second half of follow-up). In the second half of 
follow-up, compared to women who never worked rotating night shifts (IRNever=436.6.0), 
only those who worked ≥10yrs of shift work had a significantly elevated CHD risk 
(MVHR≥10yrs=1.13, 95%CI=1.04-1.24, IR≥10yrs=556.2, Ptrend=0.004). The association 
between shift work and CHD risk was not significant in the last four years of follow-up 
(2008-2012; MVHR<5yrs=0.85, 95%CI=0.70-1.03, IR<5yrs=219.9; MVHR5-9yrs=0.88, 
95%CI=0.62-1.26; IR5-9yrs=247.2, MVHR≥10yrs= 1.04, 95%CI=0.80-1.35, IR≥10yrs=306.3, 
Ptrend=0.94, eTable1).
All categories of rotating night shift work showed a significantly elevated CHD risk when 
shift work history was cumulatively updated in NHS2 (MVHR<5yrs=1.12, 
95%CI=1.01-1.24, IR<5yrs=137.4; MVHR5-9yrs=1.19, 95%CI=1.04-1.37, IR5-9yrs=161.9; 
MVHR≥10yrs=1.27, 95%CI=1.09-1.48, IR≥10yrs=190.5, Ptrend<0.001, Table 3), as compared 
to women without a history of rotating night shift work (IRNever=115.8). In NHS2, CHD risk 
also decreased with increasing time since quitting shift work (Ptrend<0.001, eTable2).
When analyses were restricted to MI and CHD deaths, overall, results were similar in NHS 
(Table 2), but attenuated in NHS2 (Table 3). Results remained largely unchanged with 
further adjustment for sleep duration and social support (eTable3).
In women without a history of diabetes, hypertension or elevated cholesterol levels, there 
was a significant trend of increased CHD risk with longer duration of shift work in NHS 
(Ptrend=0.004, Table 4), but not NHS2 (Ptrend=0.11).
In analyses stratified by BMI, a significant dose-response relationship between shift work 
and CHD risk across all BMI categories in NHS was observed (eTable4), with highest 
estimates amongst obese women (test for interaction: χ2(5) =10.9, p=0.05). In NHS2, there 
was a significant dose-response relationship between shift work and CHD risk only in obese 
women (Ptrend=0.002), but not in normal-weight or overweight women (Ptrend>0.4); the 
interaction between shift work and BMI was not significant, (χ2(5) =10.4, p=0.06).
Discussion
This prospective cohort study examined the association of rotating night shift work with 
CHD incidence, over 24 years of follow-up and found that ≥5 years of rotating night shift 
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work was associated with a significantly increased risk of CHD. The results suggest that 
recent shift work might be most relevant, as significantly stronger associations were 
observed in the first vs. second part of follow-up in NHS (27% vs. 13% increased risk for 
≥10yrs of rotating night shift work exposure), in addition to an association between 
decreasing CHD risk with increasing time since quitting shift work in NHS2. In this younger 
cohort, when using cumulatively updated shift work history, a higher CHD risk was 
observed, with a 12%, 19% and 27% increased risk for <5yrs, 5 to 9yrs, and ≥10yrs of shift 
work, respectively–Results were overall similar when restricting to women without 
hypertension, diabetes or hypercholesterolemia, suggesting that these conditions may not be 
the prime mediators of observed associations between shift work and CHD. In summary, the 
present analysis indicated that rotating night shift work was associated with increased CHD 
risk, in a duration-dependent manner, and that this risk waned over time.
Results were consistent with a recent meta-analysis that found a 23-24% increased risk of 
“any coronary event” in shift workers, despite significant heterogeneity detected across 28 
studies, presumably due to heterogeneous outcome and exposure definitions.8 The present 
study was based on a definition of rotating night shift work (≥3 night shifts/month) that has 
been used extensively in existing literature, although it did not incorporate more precise 
intensity measures related to frequency and actual working times.13,14
Lifetime history of rotating night shift work was queried on average at age 55 in NHS, when 
women are less likely to begin new shift work schedules; in NHS2, women were asked about 
shift work history when they were in their mid-thirties, with updated shift work assessments 
throughout follow-up. In NHS, CHD risk associated with rotating night shift work seemed to 
wane over time, so that after 20 years of follow-up the CHD risk associated with ≥10 years 
of exposure was not significantly elevated. In 1995, Kawachi et al.7 reported in NHS that 
≥6yrs of rotating night shift work were associated with 51% increased CHD risk after 
multivariable adjustment, based on 4 years of follow-up and 292 CHD cases. The absolute 
rate difference corresponded to 86.2/100,000 person-years (comparing never shift workers to 
women with a history of ≥10yrs of rotating night shift work) and was of modest magnitude. 
The rate difference was also comparable to the one reported in the present analysis, when 
restricting to the primary endpoints of Kawachi and colleagues (i.e., MI and CHD death) and 
the first 12 years of follow-up in NHS (crude absolute incidence rate difference=91.6).
Concomitantly, higher risk estimates for updated shift work were observed in NHS2, and 
this CHD risk significantly decreased with increasing time since quitting shift work, lending 
further support to the suggestion that recent shift work was particularly relevant for CHD 
risk – a new finding that warrants replication. Overall, the relative CHD risk associated with 
rotating night shift work was statistically significant. However, the increased CHD risk was 
found in a small group of women: those who worked 5 or more years on rotating night 
shifts, only 15 percent of all women in the study population. Hence, the absolute risk and 
public health impact of night work – given confirmation of those results – would therefore 
be small. Nonetheless, because changes in shift work schedules and associated light patterns 
potentially could reduce such risk, it is important to further explore the relation between 
shift schedules, light at night, and CHD risk.
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In this study, the CHD outcomes examined reflect trends in CHD care,15,16 including 
CABG, angiogram-confirmed angina pectoris, angioplasty and stents, in addition to 
myocardial infarction and CHD death. As stated by Hoffmann,17 a myocardial infarction 
represents a relatively late stage of a long, ongoing disease process;18 thus, the definition of 
CHD was extended by including angina pectoris and angioplasty, aiming to capture earlier 
manifestations of coronary heart disease. The analyses demonstrated a significant dose-
response relationship between rotating night shift work exposure and this more 
comprehensive CHD outcome. In NHS, results were similar when restricting analyses to MI 
and CHD death – the endpoints most other studies have examined. In NHS2, associations 
were no longer statistically significant when analyses were restricted to MI and CHD death. 
There were much fewer cases - only one in ten cases was an MI or CHD death – and thus 
less power to detect a significant association. Age differences between the two cohorts (mid-
fifties in NHS vs. mid-thirties in NHS2 at baseline in 1988 and 1989) and technological 
advances resulting in different standards of care16 may explain these findings. They also 
suggested the importance of evaluating a broader CHD endpoint in relation to shift work, as 
part of the association could otherwise be concealed by secondary and tertiary prevention.
Whether shift work was associated with increased CHD risk in the absence of hypertension, 
hypercholesterolemia and diabetes was another question of this study. A previous study 
found no association between CHD-related disability and mortality over 22-years shift- 
versus day-workers after excluding individuals with cancer, angina pectoris, non-fatal MI, 
obstructive pulmonary disease, hypertension, or diabetes mellitus prior to baseline.19 Here, 
when participants with hypertension, elevated cholesterol levels or diabetes were excluded at 
baseline and throughout follow-up, a significant dose-response relationship between rotating 
night shift work and CHD risk in NHS, but not NHS2, was observed. Overall, this analysis 
supported the hypothesis that shift work per se – and the associated disruption of biological 
and social rhythms – could have increased CHD risk, even in the absence of, or with only 
subclinical manifestations, of potentially mediating comorbidities such as hypertension, 
hypercholesterolemia or diabetes.
Obesity has been associated with a higher risk of coronary heart disease,20,21 such as 
myocardial infarction and CHD death22. All analyses were therefore adjusted for BMI 
(updated throughout follow-up) and additional analyses examined whether the effects of 
shift work varied by BMI. There was suggestive evidence for effect modification by BMI. 
Though these results warrant replication, women who were overweight might have been at 
an even higher risk for CHD if they simultaneously worked rotating night shifts. Residual 
confounding by BMI should be considered as an alternate explanation; however, as analyses 
were adjusted for BMI continuously in each stratum, this appeared a less likely explanation.
In the past two decades, sleep disturbances, psychosocial stress, and social isolation have 
been identified as important contributors to CHD risk.23-27 Therefore, additional analyses 
adjusted for sleep and social support, and results remained largely unchanged. However, 
given that shift work may affect both sleep and social support,4 further research in 
populations with more extensive information on sleep duration, quality, and timing, as well 
as work hours seems warranted. In addition, circadian misalignment –where the biological, 
endogenous rhythm is asynchronous with behavioral cycles of activity, sleep and food intake 
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– may be a key mechanism linking shift work to chronic disease,28,29 including 
cardiovascular disease.2,3,30 Future studies might also explore whether an individual's 
endogenous biological rhythm (also referred to as chronotype)31 alters the association 
between lifetime history of rotating night shift and CHD risk, as early chronotypes 
experience higher levels of circadian misalignment and sleep curtailment during night 
shifts,32 and might therefore show higher CHD risk related to rotating night shift work.
This study has several strengths of note. It is large with >10,000 incident CHD cases over 24 
years of follow-up, and confirmed endpoints of MI and CHD death by medical and death 
records. Detailed information on a wide range of potential confounding factors was 
available, and most of them were updated regularly throughout follow up. This study was 
also based on one of the few cohorts with detailed lifetime shift work exposure information.
Several limitations are also noteworthy. Conclusions can be generalized to women only, and 
health effects of shift work and pathways may be different in men and women.33 As in all 
observational studies, even though known potential confounding factors were controlled for, 
there might have been still uncontrolled confounding due to unmeasured differences in 
behaviors or other factors. This study relied on self-reports for angiogram confirmed angina 
pectoris, CABG, angioplasty and stents, but validation studies have demonstrated a high 
accuracy of self-reports from these participants, all of whom are registered nurses.34,35 The 
exposure assessments lacked information on intensity of night shift work and physiological 
measures that may be affected by shift work. Additionally, as information on permanent 
night shift work over time was not collected, women with such schedules might have been 
included in the reference group. If permanent night shift workers had a higher CHD risk as 
compared to never rotating shift workers, this would have biased results towards the null. 
Future studies should include a more detailed assessment of work hours and job demands, 
ideally in conjunction with chronotype and sleep timing measures, to enable more detailed 
studies of circadian strain on coronary health.14 Furthermore, studying CHD-related 
biomarkers (e.g., triglycerides, cholesterol levels, carotid plaque, or HbA1c)17,36 might be 
useful in understanding underlying mechanisms.
Conclusions
Among women who worked as registered nurses, longer duration of rotating night shift work 
was associated with a statistically significant, but small absolute increase in CHD risk. 
Further research is needed to explore whether the association is related to specific work 
hours and individual characteristics.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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